No. As of September 2026, Veraxa Biotech AG (VRXA) is classified as NOT HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Veraxa Biotech AG does not pass Musaffa's business and financial screening criteria.
Veraxa Biotech AG is a CH-based company operating in Biotechnology industry. The company is headquartered in Zurich, Zuerich. The company went IPO on 2026-06-11. Veraxa Biotech AG is a Switzerland-based Company that develops antibody-based therapeutics for the treatment of cancer. The firm focuses on advancing proprietary platform technologies designed to generate targeted oncology therapies with improved safety and efficacy profiles. Its approach originates from scientific discoveries at the European Molecular Biology Laboratory, supporting the development of next-generation antibody-based drug candidates. The firm aims to expand treatment options for solid tumors by enabling more precise targeting mechanisms and potentially broader therapeutic windows compared with conventional therapies, addressing unmet needs across oncology markets through platform-driven innovation.
V
Veraxa Biotech AG VRXA
$1.76 $0.23 (15.03%) 1D
Last Updated: Sep 04, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
VRXA Shariah Compliance
Screening Methodology: AAOIFI
As of September 2026, Veraxa Biotech AG is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Veraxa Biotech AG (VRXA) Chart
Financial Metrics & Statements of Veraxa Biotech AG (VRXA)
FAQ's for Veraxa Biotech AG (VRXA)
As of September 2026, Veraxa Biotech AG VRXA is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Veraxa Biotech AG using these criteria to determine its compliance status.
Muslim investors may consider investing in Veraxa Biotech AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Veraxa Biotech AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Veraxa Biotech AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Veraxa Biotech AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Veraxa Biotech AG (VRXA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.